#Discovery A big thank you to Sing Tao Daily and Headline Daily for the excellent articles highlighting the importance of G-NiiB Immunity Formula and its remarkable ability to boost the efficacy of COVID-19 vaccines. As a unique microbiome biotechnology startup in Hong Kong with a mission to transform novel microbiome signatures into ground-breaking diagnostics and effective therapeutics, our newly developed M3CRC, the world’s only non-invasive and high sensitivity colorectal

#Discovery #GenieBiome has won Supreme Brand Award 2021 by Capital CEO & Entrepreneur magazine in less than a year since our product launched. Congratulations! Rachel Fan, CEO of #GenieBiome shared, “I am immensely thankful for this award presented by Capital. I would like to show my true appreciation to the members of the jury for choosing GenieBiome as the Supreme Brand of the year. We are so proud that our iconic products, G-NiB immunity formula (#ImmunityPlus & #ImmunityP

#Discovery The Faculty of Medicine at The Chinese University of Hong Kong conducted a study to investigate the hypothesis that gut microbiome can impact vaccine response and safety. Early laboratory results suggest the microbiome immunity formula developed by CU Medicine can suppress inflammatory response associated with unwanted adverse events receiving COVID-19 vaccine.

#Discovery A recent study by CUHK Medicine found that 40% of Hong Kong people shown gut dysbiosis comparable to that of COVID-19 patients. Such dysbiosis is related to impaired immunity. With big data analysis and metagenomics derived from COVID-19 patients, researchers developed a unique microbiome immunity formula that enhances antibody formation and restore dysbiosis in COVID-19